Clinical Trials Directory

Trials / Completed

CompletedNCT00910364

Feasibility Study of Exercise in Patients With Leg Blood Clots

EXPERT Trial: Exercise to Prevent Post-thrombotic Syndrome Elicited by Recent Thrombosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
21 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this pilot study is to assess the feasibility of determining the effects of a structured exercise program started two to four weeks after diagnosis of a first episode lower-extremity deep vein thrombosis (DVT) for a period of 12 weeks in reducing the incidence of post-thrombotic syndrome (PTS).

Detailed description

Deep Vein Thrombosis (DVT) affects nearly 300,000 people in the U.S. each year. DVT of the leg results in PTS in up to 65% of patients,despite receiving appropriate medical management with anticoagulant therapy. PTS, caused by persistent venous outflow obstruction and venous valvular dysfunction, may result in symptoms of leg pain, swelling, heaviness and cramping especially with prolonged standing. All eligible patients with documented first-episode DVT interested in participating will undergo medical screening and a screening treadmill test prior to enrollment between two and four weeks post DVT diagnosis. All patients will be provided and asked to wear class II (30 to 40mmHg) knee length compression hose daily during the entire trial. The formal exercise training includes both a supervised walking program and a home-based walking program for 12 weeks with follow-up at 26 weeks. Blood tests will be taken to measure levels of indicators of inflammation at baseline, week 4, week 12, and week 26. The primary outcomes will be the feasibility of the exercise program and the incidence of post-thrombotic syndrome at 26 weeks.

Conditions

Interventions

TypeNameDescription
OTHERExerciseExercise

Timeline

Start date
2008-10-01
Primary completion
2012-12-01
Completion
2016-12-01
First posted
2009-05-29
Last updated
2017-04-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00910364. Inclusion in this directory is not an endorsement.